(Q42541694)

2 November 2017

title

Effect of long-term gastric acid suppressive therapy on serum vitamin B12 levels in patients with Zollinger-Ellison syndrome (English)

1 reference

2 November 2017

0 references

0 references

0 references

Termanini B

1

1 reference

2 November 2017

Gibril F

2

1 reference

2 November 2017

Sutliff VE

3

1 reference

2 November 2017

Yu F

4

1 reference

2 November 2017

Venzon DJ

5

1 reference

2 November 2017

Jensen RT

6

1 reference

2 November 2017

language of work or name

English

0 references

publication date

1 May 1998

1 reference

American Journal of Medicine

2 November 2017

published in

1 reference

2 November 2017

volume

104

1 reference

2 November 2017

issue

5

1 reference

2 November 2017

page(s)

422-430

1 reference

Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome

2 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900087-4

Omeprazole. An update of its pharmacology and therapeutic use in acid-related disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900087-4

Effect of long-term treatment with omeprazole on serum gastrin and serum group A and C pepsinogens in patients with reflux esophagitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900087-4

Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900087-4

Vitamin B12 malabsorption and omeprazole therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900087-4

Comment on the Paper by Waldum et al. Risks of Hypergastrinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900087-4

Serum Iron, Ferritin, and Vitamin B12 During Prolonged Omeprazole Therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900087-4

Effect of hypochlorhydria due to omeprazole treatment or atrophic gastritis on protein-bound vitamin B12 absorption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900087-4

Omeprazole therapy causes malabsorption of cyanocobalamin (vitamin B12)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900087-4

The effect of omeprazole on gastric acidity and the absorption of liver cobalamins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900087-4

Use of omeprazole in Zollinger-Ellison syndrome: a prospective nine-year study of efficacy and safety.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900087-4

Assessment and prediction of long-term cure in patients with the Zollinger-Ellison syndrome: the best approach.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900087-4

Secretin and calcium provocative tests in the Zollinger-Ellison syndrome. A prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900087-4

Control of gastric acid hypersecretion in the management of patients with Zollinger-Ellison syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900087-4

Selective venous sampling for gastrin to localize gastrinomas. A prospective assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900087-4

Zollinger-Ellison syndrome can be the initial endocrine manifestation in patients with multiple endocrine neoplasia-type I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900087-4

Currently used doses of omeprazole in Zollinger-Ellison syndrome are too high

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900087-4

Reflux esophagitis in patients with Zollinger-Ellison syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900087-4

Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900087-4

Effect of omeprazole on the secretion of intrinsic factor, gastric acid and pepsin in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900087-4

Hematologic alterations following partial gastrectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900087-4

Elevated methylmalonic acid and total homocysteine levels show high prevalence of vitamin B12 deficiency after gastric surgery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900087-4

Prevalence of cobalamin deficiency in the Framingham elderly population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900087-4

Metabolic evidence that deficiencies of vitamin B-12 (cobalamin), folate, and vitamin B-6 occur commonly in elderly people

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900087-4

Clinically significant vitamin B12 deficiency secondary to malabsorption of protein-bound vitamin B12

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900087-4

Reversal of protein-bound vitamin B12 malabsorption with antibiotics in atrophic gastritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900087-4

Bacterial overgrowth without clinical malabsorption in elderly hypochlorhydric subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900087-4

Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900087-4

Cimetidine and malabsorption of cobalamin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900087-4

Malabsorption of protein-bound cobalamin but not unbound cobalamin during cimetidine administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900087-4

Effect of cimetidine on the absorption of vitamin B12

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900087-4

Effect of ranitidine on cobalamin absorption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900087-4

Twenty-four-hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900087-4

Famotidine in the therapy of gastric hypersecretory states

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900087-4

Cimetidine pharmacokinetics in patients with Zollinger-Ellison syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900087-4

Effects of omeprazole on acid secretion and acid-related symptoms in patients with Zollinger-Ellison syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900087-4

Use of omeprazole in patients with Zollinger-Ellison syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900087-4

Curative resection in Zollinger-Ellison syndrome. Results of a 10-year prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900087-4

Gastrin-producing tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900087-4

Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900087-4

Impaired antibody responses to pneumococcal polysaccharide in elderly patients with low serum vitamin B12 levels.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900087-4

REVERSIBLE HYPOGAMMAGLOBULINAEMIA IN CYANOCOBALAMIN (B12) DEFICIENCY

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900087-4

Immunoglobulin deficiency responding to vitamin B12 in two elderly patients with megaloblastic anaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900087-4

Subtle cobalamin deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900087-4

Long-Term Omeprazole Treatment in Man: Effects on Gastric Endocrine Cell Populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900087-4

Healing and relapse of severe peptic esophagitis after treatment with omeprazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900087-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Intrinsic Factor Secretion and Cobalamin Absorption: Physiology and Pathophysiology in the Gastrointestinal Tract

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900087-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Long-term efficacy and safety of omeprazole in patients with Zollinger-Ellison syndrome: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900087-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(98)00087-4

1 reference

2 November 2017

1 reference